Value Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$465K Hold
8,600
0.29% 20
2016
Q1
$444K Buy
+8,600
New +$447K 0.4% 16

Other funds holding XBI

Value Partners's XBI Position: Q2 2016 in Review

Value Partners held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2016 at 8,600 shares worth $465K. The position accounts for 0.29% of the portfolio, ranked #20.

Value Partners first reported a position in XBI in Q1 2016 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold XBI as of Q2 2016.

  • Value Partners held 8,600 shares of State Street SPDR S&P Biotech ETF worth $465K as of Q2 2016.
  • Value Partners left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2016.
  • State Street SPDR S&P Biotech ETF made up 0.29% of Value Partners's portfolio in Q2 2016, its #20 holding.
  • Value Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2016 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2016.

Based on Value Partners's 13F filing for Q2 2016, filed 12 Aug 2016.